Laura Braeuninger-Weimer, joined as the Head of Venture Operations in March 2016. Previously, Laura started as an Intern/Analyst in July 2014 and soon transitioned into a permanent position in the Global Business Development and Licensing Oncology team in the biopharma division of Merck KGaA, Darmstadt, Germany. She was working on several transactions within her role including being a core member of the Due Diligence team for the Pfizer PD-L1 deal among others. In the last 4 months before joining Merck Ventures, Laura was seconded to Rehan Verjee, Chief Marketing and Strategy Officer as interim Head of Office to support with the implementation and acceleration of key priorities. Laura is a graduate in Economics having studied in Paris (American University of Paris), Frankfurt (Frankfurt School of Finance and Management - Bachelor), Sydney (University of New South Wales) and Zurich (University of Zurich - Master). Laura is based in Darmstadt.